Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
Citado por SciELO
Accesos
Links relacionados
Citado por Google
Similares en SciELO
Similares en Google
Compartir
Revista Española de Enfermedades Digestivas
versión impresa ISSN 1130-0108
Resumen
CUENCA, F. et al. Experience with granulocytapheresis in Crohn's disease. Rev. esp. enferm. dig. [online]. 2004, vol.96, n.7, pp.501-506. ISSN 1130-0108.
Objective: to describe our experience with granulocyte apheresis to induce remission in patients with active Crohn's disease refractory to conventional treatment. We summarize the results previously obtained with this technique. Conclusions: granulocyte apheresis is a safe and well tolerated therapeutic modality that can be a valid therapeutic alternative in the induction of remission in inflammatory bowel disease, although controlled clinical trials must be conducted to define long-term efficacy, as well as to establish “optimal patient” selection, re-treatment interval, and number of sessions.
Palabras clave : Granulocyte apheresis; Leukocyte apheresis; Ulcerative colitis; Crohn's disease; Inflammatory bowel disease.